The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock
Key facts
- Who runs it
- Shusheng Li
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 118 people enrolled
- Started
- 1 Apr 2025
- Ended
- 28 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- critical ultrasonography
- Record updated
- 30 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- 1. Age ≥ 18 years old
- 2. Estimated length of ICU stay ≥ 24 hours
- 3. Diagnosis according to the Sepsis 3.0 criteria, which included:
- a. suspected or confirmed infections supported by clinical evidence and/or positive microbiological findings
- b. the sepsis related organ failure assessment (SOFA) score ≥ 2
Who cannot take part
- 8. Patients had drug poisoning
- 2. Patients had acute coronary syndrome
- 5. Patients had malignant arrhythmia
- 6. Patients had active gastrointestinal bleeding
- 7. Patients had epileptic seizure
- 11. Patients had intra-abdominal hypertension (intra-abdominal pressure increases continuously ≥ 12mmHg)
- 14. Patients had cardiac structural or functional abnormalities (left ventricular outflow tract obstruction, moderate-to-severe mitral regurgitation, aortic regurgitation), it would seriously affect the velocity time integral of left ventricular outflow tract
- 1. Patients were pregnant woman
- 3. Patients had acute pulmonary edema
- 4. Patients had status asthmatics
- 9. Patients had severe burns
- 10. Patients had contraindications of blood transfusion
- 12. Patients had acute pulmonary embolism
- 13. Patients had contraindications of leg raising
- 15. Patients or their legal representatives refused active treatment
- 16. Patients or their legal representatives refused to participate in this study
- 17. Patients were participating in other interventional clinical trials
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess whether procedural critical ultrasonography guided precise fluid management (CUGP) can affect the clinical fluid management strategy and improve the outcomes of patients with sepsis or septic shock.
The 2 groups in the trial
- CUGP groupTreatment being tested
In the CUGP group, ultrasonographic assessment was performed by a team of trained critical ultrasonography physicians at enrollment, 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours thereafter, respectively.
Treatment: critical ultrasonography
- usual care groupNo study treatment, for comparison
The usual care group used conventional hemodynamic monitoring methods for monitoring and decision-making about fluid management. Records were made at enrollment, 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours thereafter, respectively.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Critical Ultrasonography Guided Precise Fluid Management in Patients With Sepsis or Septic Shock: A Single-center Randomized Controlled Trial
- Record updated
- 30 January 2026